USPTO serial 97618886
VIAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 19, 2023
- Examiner
- ANKRAH, NAAKWAMA S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with VIAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica L. Rothstein
Jessica L. Rothstein GOODWIN PROCTER LLP620 Eighth AvenueNew York, NY 10018United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, biotechnology, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic, and device approval; Providing independent review of clinical trials for business purposes; Maintaining a registry of patients, namely, compilation of patient information into computer databases; Business management consulting and advisory services in pharmaceutical, biotechnology, medical, healthcare, and life sciences fields; Market analysis and research services; Business market consulting; Business consulting and information services; Providing computerized database management and data processing services in the pharmaceutical, biotechnology, medical, healthcare, and life sciences fields; Recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of drugs, biologics, and devices; Providing a website featuring business information in the pharmaceutical, medical, healthcare, and life sciences fields | ACTIVE | Aug 30, 2020 |
| 041 | On-line journals, namely, blogs featuring information relating to clinical trials; Providing a website featuring blogs and non-downloadable publications in the nature of articles and white papers relating to clinical trials; Providing online non-downloadable videos featuring information relating to clinical trials | ACTIVE | Apr 2, 2021 |
| 042 | Providing online, non-downloadable software for providing pharmaceutical, biotechnology, medical, healthcare, and life sciences information and analysis; Platform as a service (PAAS) featuring computer software platform for providing, collecting, and analyzing pharmaceutical, biotechnology, medical, healthcare, and life sciences information; Platform as a service (PAAS) featuring computer software platform for collecting, managing, and analyzing clinical trial data; Computer services, namely, providing on-line, non-downloadable computer software used for accessing, collecting, managing, tracking, analyzing, and reporting data in clinical research and drug development; Providing temporary use of on-line non-downloadable software for use in healthcare and electronic health record management; Providing electronic data capture and data management systems, namely, providing temporary use of online, non-downloadable software for collection and management of healthcare and life sciences data; Scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical, biotechnology, medical, healthcare, and life sciences; Clinical research, clinical testing, and laboratory testing services in the pharmaceutical, biotechnology, medical, healthcare, and life sciences fields; Research and development in the fields of pharmaceutical, biotechnology, medical, healthcare, and life sciences; Pharmaceutical drug development services, namely, developing clinical trial methodologies; Providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical, and biotechnology companies; Consulting services in the field of contract clinical research and contract product development | ACTIVE | Aug 30, 2020 |
| 044 | Providing health, medical, pharmaceutical, health management and disease management information to others; Providing medical information to physicians, other health care professionals, and medical patients | ACTIVE | Aug 30, 2020 |
| 045 | Regulatory compliance legal research in the field of development of drugs, devices, biologics, and methodologies used in the pharmaceutical industry and medical industry; Regulatory compliance consulting in the pharmaceutical, biotechnology, medical, healthcare, and life sciences fields; Providing regulatory information, namely, legal information regarding compliance with pharmaceutical, biotechnology, medical, healthcare, and life sciences regulations; Providing regulatory implementation services, namely, regulatory compliance consulting in the fields of the development, validation, and production of drugs, biologics, and devices | ACTIVE | Aug 30, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vial Health Technology Inc.
- Other trademarks owned by Vial Health Technology Inc.
- Other trademarks owned by Vial Health Technology Inc.
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named VIAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 11, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 11, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 11, 2025 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Aug 11, 2025 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Mar 24, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 24, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 24, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 24, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 25, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 25, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 25, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 25, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 25, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 20, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 20, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 20, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 19, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 19, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 3, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 3, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 13, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 25, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 22, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 22, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 19, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 21, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 20, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 7, 2022 | NWAP | NEW APPLICATION ENTERED | — |